CCO Official Conference Coverage
2008 AASLD Meeting*
October 31-November 4, 2008 | San Francisco, California
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Advances in HBV Treatment With Approved Agents
|
Track 1 of 5
|
|
|
|
   |
- Jules L. Dienstag, MD
- Robert G. Gish, MD
- Ira M. Jacobson, MD
|
|
|
2008 Update on the Use of Approved HCV Agents
|
Track 2 of 5
|
|
|
|
   |
- Gregory T. Everson, MD, FACP
- Carroll Leevy, MD
- K. Rajender Reddy, MD
|
|
|
Focus on Investigational HBV/HCV Agents
|
Track 3 of 5
|
|
|
|
   |
- Nezam H. Afdhal, MD, FRCPI
- Fred Poordad, MD
- Stefan Zeuzem, MD
|
|
|
HBV Expert Recap of AASLD 2008
|
Track 4 of 5
|
HCV Expert Recap of AASLD 2008
|
Track 5 of 5
|
CCO Slideset
HBV Highlights
 |
|
This downloadable slideset reviews key hepatitis B data from the 2008 AASLD meeting and shows how these data relate to the current management of hepatitis B.
Format: Microsoft PowerPoint (.ppt) |
File size: 834 KB
| Date posted: 1/14/2009
|
Expert Highlights
Choose a highlight from the list below:
|
|
|
Disclaimer:
The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
Capsule Summary:
|
|